The United States Recombinant Peptides Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Recombinant Peptides industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Recombinant Peptides market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Recombinant Peptides industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 149 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
1 Industry Overview
1.1 Definition and Specifications of Recombinant Peptides
1.2 Classification of Recombinant Peptides
1.2.1 Glucagon
1.2.2 Calcitonin
1.2.3 Others
1.3 Applications of Recombinant Peptides
1.4 Industry Chain Structure of Recombinant Peptides
1.5 Industry Overview of Recombinant Peptides
1.6 Industry Policy Analysis of Recombinant Peptides
1.7 Industry News Analysis of Recombinant Peptides
2 Manufacturing Cost Structure Analysis of Recombinant Peptides
2.1 Bill of Materials (BOM) of Recombinant Peptides
2.2 BOM Price Analysis of Recombinant Peptides
2.3 Labor Cost Analysis of Recombinant Peptides
2.4 Depreciation Cost Analysis of Recombinant Peptides
2.5 Manufacturing Cost Structure Analysis of Recombinant Peptides
2.6 Manufacturing Process Analysis of Recombinant Peptides
2.7 China Price, Cost and Gross of Recombinant Peptides 2010-2015
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Recombinant Peptides Manufacturers in 2014
3.3 R & D Status and Technology Source of United States Recombinant Peptides Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Recombinant Peptides Key Manufacturers in 2014
4 Production Analysis of Recombinant Peptides by Regions, Type, and Applications
4.1 United States Production of Recombinant Peptides by Regions 2010-2015
4.2 United States Production of Recombinant Peptides by Type 2010-2015
4.3 United States Sales of Recombinant Peptides by Applications 2010-2015
4.4 Price Analysis of United States Recombinant Peptides Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Recombinant Peptides 2010-2015
5 Consumption Volume and Consumption Value Analysis of Recombinant Peptides by Regions
5.1 United States Consumption Volume of Recombinant Peptides by Regions 2010-2015
5.2 United States Consumption Value of Recombinant Peptides by Regions 2010-2015
5.3 United States Consumption Price Analysis of Recombinant Peptides by Regions 2010-2015
6 Analysis of Recombinant Peptides Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Recombinant Peptides 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Recombinant Peptides 2014-2015
6.3 Sales Overview of Recombinant Peptides 2010-2015
6.4 Supply, Consumption and Gap of Recombinant Peptides 2010-2015
6.5 Import, Export and Consumption of Recombinant Peptides 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Recombinant Peptides 2010-2015
7 Analysis of Recombinant Peptides Industry Key Manufacturers
7.1 Hospira
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Hospira SWOT Analysis
7.2 Sandoz International (Division Of Novartis International )
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Sandoz International (Division Of Novartis International ) SWOT Analysis
7.3 Teva
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Teva SWOT Analysis
7.4 Roche
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Roche SWOT Analysis
7.5 Amgen
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Amgen SWOT Analysis
7.6 Biocon
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Biocon SWOT Analysis
7.7 Dr. Reddy's Laboratories
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Dr. Reddy's Laboratories SWOT Analysis
7.8 Celltrion
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Celltrion SWOT Analysis
7.9 Mylan
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Mylan SWOT Analysis
7.10 Actavis
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Actavis SWOT Analysis
7.11 Merck
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Merck SWOT Analysis
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Recombinant Peptides Product Types
8.5 Market Share Analysis of Different Recombinant Peptides Price Levels
8.6 Gross Margin Analysis of Different Recombinant Peptides Applications
9 Marketing Trader or Distributor Analysis of Recombinant Peptides
9.1 Marketing Channels Status of Recombinant Peptides
9.2 Traders or Distributors of Recombinant Peptides with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Recombinant Peptides
9.4 United States Import, Export and Trade Analysis of Recombinant Peptides
10 Development Trend of Recombinant Peptides Industry 2016-2021
10.1 Capacity and Production Overview of Recombinant Peptides 2016-2021
10.2 Production Market Share by Product Types of Recombinant Peptides 2016-2021
10.3 Sales and Sales Revenue Overview of Recombinant Peptides 2016-2021
10.4 United States Sales of Recombinant Peptides by Applications 2016-2021
10.5 Import, Export and Consumption of Recombinant Peptides 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Recombinant Peptides 2016-2021
11 Industry Chain Suppliers of Recombinant Peptides with Contact Information
11.1 Major Raw Materials Suppliers of Recombinant Peptides with Contact Information
11.2 Manufacturing Equipment Suppliers of Recombinant Peptides with Contact Information
11.3 Major Players of Recombinant Peptides with Contact Information
11.4 Key Consumers of Recombinant Peptides with Contact Information
11.5 Supply Chain Relationship Analysis of Recombinant Peptides
12 New Project Investment Feasibility Analysis of Recombinant Peptides
12.1 New Project SWOT Analysis of Recombinant Peptides
12.2 New Project Investment Feasibility Analysis of Recombinant Peptides
13 Conclusion of the United States Recombinant Peptides Industry 2015 Deep Market Research Report
List of Tables and Figures
Figure Picture of Recombinant Peptides
Table Product Specifications of Recombinant Peptides
Table Classification of Recombinant Peptides
Figure United States Sales Market Share of Recombinant Peptides by Product Types in 2014
Table Applications of Recombinant Peptides
Figure United States Sales Market Share of Recombinant Peptides by Applications in 2014
Figure Industry Chain Structure of Recombinant Peptides
Table United States Industry Overview of Recombinant Peptides
Table Industry Policy of Recombinant Peptides
Table Industry News List of Recombinant Peptides
Table Bill of Materials (BOM) of Recombinant Peptides
Table Bill of Materials (BOM) Price of Recombinant Peptides
Table Labor Cost of Recombinant Peptides
Table Depreciation Cost of Recombinant Peptides
Table Manufacturing Cost Structure Analysis of Recombinant Peptides in 2014
Figure Manufacturing Process Analysis of Recombinant Peptides
Table United States Price Analysis of Recombinant Peptides 2010-2015 (USD/Dose)
Table United States Cost Analysis of Recombinant Peptides 2010-2015 (USD/Dose)
Table United States Gross Analysis of Recombinant Peptides 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Recombinant Peptides Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Recombinant Peptides Manufacturers in 2014
Table R & D Status and Technology Source of United States Recombinant Peptides Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Recombinant Peptides Key Manufacturers in 2014
Table United States Production of Recombinant Peptides by Regions 2010-2015 (Doses)
Table United States Production Market Share of Recombinant Peptides by Regions 2010-2015
Figure United States Production Market Share of Recombinant Peptides by Regions in 2014
Figure United States Production Market Share of Recombinant Peptides by Regions in 2015
Table United States Production of Recombinant Peptides by Types in 2010-2015 (Doses)
Table United States Production Market Share of Recombinant Peptides by Type in 2010-2015
Figure United States Production Market Share of Recombinant Peptides by Type in 2014
Figure United States Production Market Share of Recombinant Peptides by Type in 2015
Table United States Sales of Recombinant Peptides by Applications 2010-2015 (Doses)
Table United States Production Market Share of Recombinant Peptides by Applications 2010-2015
Figure United States Production Market Share of Recombinant Peptides by Applications in 2014
Figure United States Production Market Share of Recombinant Peptides by Applications in 2015
Table Price Comparison of United States Recombinant Peptides Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Recombinant Peptides 2010-2015
Table United States Consumption Volume of Recombinant Peptides by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Recombinant Peptides by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Recombinant Peptides by Regions in 2014
Figure United States Consumption Volume Market Share of Recombinant Peptides by Regions in 2015
Table United States Consumption Value of Recombinant Peptides by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Recombinant Peptides by Regions 2010-2015
Figure United States Consumption Value Market Share of Recombinant Peptides by Regions in 2014
Figure United States Consumption Value Market Share of Recombinant Peptides by Regions in 2015
Table Consumption Price of Recombinant Peptides by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Recombinant Peptides 2010-2015 (Doses)
Table United States Capacity Market Share of Major Recombinant Peptides Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Recombinant Peptides 2010-2015 (Doses)
Table United States Production Market Share of Major Recombinant Peptides Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Recombinant Peptides 2010-2015 (Doses)
Table United States Sales Market Share of Major Recombinant Peptides Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Recombinant Peptides 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Recombinant Peptides Manufacturers 2010-2015
Figure United States Capacity (Doses) , Production (Doses) and Growth Rate of Recombinant Peptides 2010-2015
Figure United States Capacity Utilization Rate of Recombinant Peptides 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Recombinant Peptides 2010-2015
Figure United States Production Market Share of Major Recombinant Peptides Manufacturers in 2014
Figure United States Production Market Share of Major Recombinant Peptides Manufacturers in 2015
Figure United States Sales Market Share of Major Recombinant Peptides Manufacturers in 2014
Figure United States Sales Market Share of Major Recombinant Peptides Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Recombinant Peptides 2010-2015
Table United States Supply, Consumption and Gap of Recombinant Peptides 2010-2015 (Doses)
Table United States Import, Export and Consumption of Recombinant Peptides 2010-2015 (Doses)
Table Price of United States Recombinant Peptides Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Recombinant Peptides Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Recombinant Peptides 2010-2015 (M USD)
Table United States Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Revenue (M USD) and Gross Margin of Recombinant Peptides 2010-2015
Table Hospira Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Hospira
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Hospira 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Hospira 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Hospira 2010-2015
Table Hospira Recombinant Peptides SWOT Analysis
Table Sandoz International (Division Of Novartis International ) Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Sandoz International (Division Of Novartis International )
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Sandoz International (Division Of Novartis International ) 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Sandoz International (Division Of Novartis International ) 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Sandoz International (Division Of Novartis International ) 2010-2015
Table Sandoz International (Division Of Novartis International ) Recombinant Peptides SWOT Analysis
Table Teva Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Teva
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Teva 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Teva 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Teva 2010-2015
Table Teva Recombinant Peptides SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Roche
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Roche 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Recombinant Peptides SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Amgen
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Amgen 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Amgen 2010-2015
Table Amgen Recombinant Peptides SWOT Analysis
Table Biocon Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Biocon
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Biocon 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Biocon 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Biocon 2010-2015
Table Biocon Recombinant Peptides SWOT Analysis
Table Dr. Reddy's Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Dr. Reddy's Laboratories
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Dr. Reddy's Laboratories 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Dr. Reddy's Laboratories 2010-2015
Table Dr. Reddy's Laboratories Recombinant Peptides SWOT Analysis
Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Celltrion
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Celltrion 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Celltrion 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Celltrion 2010-2015
Table Celltrion Recombinant Peptides SWOT Analysis
Table Mylan Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Mylan
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Mylan 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Mylan 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Mylan 2010-2015
Table Mylan Recombinant Peptides SWOT Analysis
Table Actavis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Actavis
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Actavis 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Actavis 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Actavis 2010-2015
Table Actavis Recombinant Peptides SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Recombinant Peptides Picture and Specifications of Merck
Table Recombinant Peptides Capacity (Doses) , Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Gross (USD/Dose) , Revenue (M USD) and Gross Margin of Merck 2010-2015
Figure Recombinant Peptides Capacity (Doses) , Production (Doses) and Growth Rate of Merck 2010-2015
Figure Recombinant Peptides Production (Doses) and United States Market Share of Merck 2010-2015
Table Merck Recombinant Peptides SWOT Analysis
Table Recombinant Peptides Price by Regions 2010-2015
Table Recombinant Peptides Price by Product Types 2010-2015
Table Recombinant Peptides Price by Companies 2010-2015
Table Recombinant Peptides Gross Margin by Companies 2010-2015
Table Price Comparison of Recombinant Peptides by Regions 2010-2015 (USD/Dose)
Table Price of Different Recombinant Peptides Product Types (USD/Dose)
Table Market Share of Different Recombinant Peptides Price Level
Table Gross Margin of Different Recombinant Peptides Applications
Table Marketing Channels Status of Recombinant Peptides
Table Traders or Distributors of Recombinant Peptides with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Recombinant Peptides (USD/Dose) in 2015
Table United States Import, Export, and Trade of Recombinant Peptides (Doses)
Figure United States Capacity (Doses) , Production (Doses) and Growth Rate of Recombinant Peptides 2016-2021
Figure United States Capacity Utilization Rate of Recombinant Peptides 2016-2021
Table United States Recombinant Peptides Production by Type 2016-2021 (Doses)
Table United States Recombinant Peptides Production Market Share by Type 2016-2021
Figure United States Production Market Share of Recombinant Peptides by Type in 2021
Figure United States Sales (Doses) and Growth Rate of Recombinant Peptides 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Recombinant Peptides 2016-2021
Figure United States Sales of Recombinant Peptides by Applications 2016-2021 (Doses)
Table United States Production Market Share of Recombinant Peptides by Applications 2016-2021
Figure United States Production Market Share of Recombinant Peptides by Applications in 2021
Table United States Production, Import, Export and Consumption of Recombinant Peptides 2016-2021 (Doses)
Table United States Production (Doses) , Price (USD/Dose) , Cost (USD/Dose) , Revenue (M USD) and Gross Margin of Recombinant Peptides 2016-2021
Table Major Raw Materials Suppliers of Recombinant Peptides with Contact Information
Table Manufacturing Equipment Suppliers of Recombinant Peptides with Contact Information
Table Major Players of Recombinant Peptides with Contact Information
Table Key Consumers of Recombinant Peptides with Contact Information
Table Supply Chain Relationship Analysis of Recombinant Peptides
Table New Project SWOT Analysis of Recombinant Peptides
Table New Project Investment Feasibility Analysis of Recombinant Peptides
Table Part of Interviewees Record List
